Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 35 for “"Drug pricing"”.
-
Game-theoretic analysis of network formation and drug pricing
… use of secret rebates during the negotiations on drug prices. Secret rebates enable to hide the price a country pays for a pharmaceutical product from other countries. Two models of the interactions between public payers (countries) and a monopolist pharmaceutical firm are presented to rationalize …
-
The economics of safety-net programs: evidence from the 340B Drug Pricing Program
… Elizabeth Watts) studying the growth of the 340B Drug Pricing Program, a safety-net program that is responsible for nearly 10% of annual pharmaceutical spending in the United States. The two articles presented in this chapter are adapted from versions that have been published in JAMA Health Forum …
-
The Impact Of The 340B Drug Pricing Program On Post-Launch Drug Prices
Government mandated drug-pricing policies are an understudied—but potentially significant—factor in the price of drugs. The 340B program is one of the more controversial government-mandated prescription drug discount programs. Proponents argue that the program helps health care systems cover the …
-
The Evolution Of Aids Service Organizations: The Impact Of The 340B Drug Pricing Program
… the impact of their participation in the 340B Drug Pricing Program. The research, grounded in the Resource-Based View (RBV) theory, explores how the 340B program as a unique organizational resource may lead to mission expansion and an increase in service offerings among ASOs. By comparing ASOs …
-
Funding the U.S. healthcare safety net: implications and opportunities of the 340B drug pricing program
This dissertation examines the role of the 340B Drug Pricing Program in the US health care safety-net and its implications for access, affordability, and health equity. The 340B Program allows certain hospitals and public health clinics that serve a disproportionate share of low-income patients to …
-
The 340B Drug Pricing Program: Are 340B Covered Entities Providing More Services and More Uncompensated Care?
The 340B Drug Pricing Program enacted in 1992 requires pharmaceutical manufacturers participating in the Medicaid program to provide statutorily defined discounts on "covered outpatient drugs" purchased by government-supported facilities, known as covered entities, that are expected to serve the …
-
Patents and fundamental rights in U.S. law: Excessive drug pricing as an instance of Unfair Competition
… consumers struggle to obtain the drugs on which they depend to maintain a subsistence level of health due to the exorbitant drug pricing. As a result, they face a dilemma between paying the prices charged for access to the drugs or continued ill health. I believe that denying …
-
Effects of the 340B Drug Pricing Program on Hospitals’ Prescribing Behavior, Patient Mix, and Quality of Care
In 1992, Congress created the 340B Drug Pricing Program that requires drug manufacturers to provide outpatient drugs to participating hospitals with substantial discounts. Although the intent of the program is to allow covered entities to increase access to care for more vulnerable patients, …
-
Evaluating Cost Savings and Patient Benefit from the 340B Drug Pricing Program through Expansion of Pediatric Outpatient Pharmacy Services
PURPOSE: The 340B Drug Pricing Program was established in 1992 for covered entities to stretch Federal resources and provide eligible patients with comprehensive services. Pediatric hospitals were recognized as eligible for the 340B program in 2006. There are limited reports on expanding access to …
-
Impact Of Federally Qualified Health Centers (Fqhc) And Look-Alikes (Fqhc Lal) Participating In The 340B Drug Pricing Program
The 340B Drug Pricing Program intends to enable community health providers to deliver care more easily to vulnerable populations. Safety net providers were designated as eligible entities through an act of Congress and were allowed access to prescription drug savings. Existing studies have focused …
-
Evaluating the Impact of Biosimilars in the Drug Market
Drug pricing has increase to the point where many Americans are unable to afford prescriptions for both long- and short-term diseases. Within the last decade, U.S lawmakers have changed legislation so that biosimilars can be added into the drug market in hopes of creating affordable products. …
-
COST-EFFECTIVENESS ANALYSIS OF DIRECT-ACTING ANTIVIRAL STRATEGIES FOR HEPATITIS C POSITIVE DONOR TO NEGATIVE RECIPIENT KIDNEY TRANSPLANTATION
… real-world transmission data and the most recent drug pricing. We sought to determine the most cost-efficient DAA strategy using data from the Ultra-short <strong>D</strong>irect acting <strong>A</strong>nti-viral <strong>P</strong>rophylaxis to <strong>P</strong>r<strong>e</strong>vent virus …
-
HIV/AIDS and democracy in Nigeria: Policies, rights, and therapeutic economies
… among international and local actors; (c) global drug pricing practices and their relationship to drug distribution infrastructures as well as new biosocial relations that form around lack of treatment access; and (d) a case study of HIV/AIDS cure claims over which the veracity of such claims were …
-
Essays on Health and Labour Economics
… privately insured utilization of the same drugs. The analysis documents substantial and persistent increases in private utilization following public coverage and investigates mechanisms including signaling, prescribing behavior, insurer adaptation, and substitution. The third essay …
-
A Multi-dimensional Macrolevel Study of Drug Enforcement Strategies, Heroin Prices, and Heroin Consumption Rates
… deterrent-based policing agenda to curb illicit drug trafficking and use that relies on the principles of the economic price elasticity of demand (Boynum & Reuter, 2005). This counter-drug platform includes three fundamental programs: arresting offenders, seizing illicit drugs, and eradicating …
-
How Can a CRO-Specific Leadership Framework be Developed to Enhance the Effectiveness and Efficiency of CRO Leaders in Managing Clinical Trials?
… treatments. While many factors influence drug pricing, reducing development costs through efficient CRO operations and effective leadership can support more competitive pricing and improved access. This project aimed to establish a CRO-specific Leadership Framework by conducting interviews …
-
Reducing Provincial Drug Plan Costs Through Regional Pooled-Purchasing Agreements
… health ministries are facing rising provincial drug plan costs that can be attributed to rising medication costs and increasing drug plan claims. Provinces currently employ a collection of policy tools that have not proven to be effective in reducing the cost of these essential programs. Current …
-
Improvement of global access to life-saving medicines. Facing the future.
… surveys with the main stakeholders: authorities, drug-developers and NGOs/foundations. It revealed the following determinants, which contributed to the occurrence of drug pricing conflicts in Brazil, Thailand and South Africa: governmental constitutional commitments to supply medicines to poor …
-
A study of the social causes of over-medication in China
… relate to the phenomenon of prescription drug over-use. The study has mainly used documentary and interview research methods. The primary methods of data collection are: 1) a review of documents and literatures obtained from governmental (e.g. MOH report and Year Book of Public Health, …
-
Variability in Pricing of Generic Antipsychotic Medications Used in the Treatment of Schizophrenia at Community Pharmacies in the Kansas City Metropolitan Area
… examining variability in generic medication pricing at community pharmacies have revealed conflicting results. No studies have examined variability in costs of antipsychotic medications or if these costs vary across types of pharmacies. Specifically, comparative drug pricing for generic …
Page 1 of 2